-
Science Saturday: Time tempers anthracyclines into a toxin or treatment for cancer
Share this:
For the millions of people who could face a cancer diagnosis this year, it's vital to have all therapeutic options available.
But in some cases, the drugs used to treat cancer can cause other health problems during treatment or later. One example is a class of drugs called anthracyclines, which are derived from bacteria found in Italian soil decades ago. This group of about six chemotherapy drugs has been used since the 1960s to treat leukemia, lymphoma, sarcoma and breast cancer, as well as other cancers that have spread from their original site. But a serious side effect of anthracyclines is heart damage either during treatment — which means patients must stop using it — or weeks, months or even years later. This heart damage can decrease the quality and duration of a former cancer patient's life.
To find the best path for care, a team of clinician-researchers and discovery scientists report on a potential way to prevent or heal heart damage when anthracyclines are used to treat cancer. The paper is published in Circulation Research.
Read the rest of the article on the Discovery's Edge blog.
____________________________________________
Other Mayo Clinic medical research websites:
- Research at Mayo Clinic
- Advancing the Science
- Mayo Clinic Laboratories
- Forefront
- Center for Individualized Medicine
- Center for Regenerative Medicine
- Center for the Science of Health Care Delivery
- Mayo Clinic Cancer Center
Share this:
Related articles
Researchers at the Polycystic Kidney Disease (PKD) Center at Mayo Clinic now use artificial intelligence (AI) to assess total kidney volume, generating results in a ...
Harnessing the power of patients’ lived experiences and their biospecimen data, a unique relationship between a nonprofit patient advocacy group called The MOG Project, a team ...
Mayo Clinic scientists are building an expansive library of DNA blueprints of disease-causing bacterial species. The unique collection of genomic sequences is serving as a ...